off-label use of glp-1 agonists for obesity in 2016 diabetes and anti-obesity drugs surges nationwide GLP-1 Medications for Weight Loss:

2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults

Despite its rarity, lipodystrophy represents a serious medical issue because it can interfere with drug uptake while also causing aesthetic problems [45]

Apart from WEGOVY, SAXENDA , another Novo Nordisk weight loss drug, is also approved in the US for obesity

178,180 The PI3K/Akt signaling pathway, activated by GLP-1, plays a vital role in maintaining pancreatic -cell survival and promoting their proliferation

Beneficial Cardiometabolic Effects: They do not reduce CVD risk per se but are likely to contribute to favorable lipid profiles, lower blood pressure, and reduced inflammation, consequently potentially supporting heart health indirectly

Set realistic goals: Help patients set achievable weight loss and fitness goals that they can maintain in the long run